Results 201 to 210 of about 181,689 (337)

A newly proposed endoscopic score system to evaluate the entire small bowel and predict the prognosis in Crohn’s disease [PDF]

open access: yes
Small bowel stenosis in patients with Crohn’s disease leads to abdominal symptoms and can affect prognosis. The Simple Endoscopic Score for Crohn’s Disease for the large bowel has been applied to the small bowel; however, stenosis scoring may be ...
Furukawa, Kazuhiro   +16 more
core  

Expression of the T-Cell Chemoattractant Chemokine Lymphotactin in Crohn’s Disease [PDF]

open access: bronze, 2001
Peter Middel   +9 more
openalex   +1 more source

Refractory Pyostomatitis Vegetans With Multiple Aseptic Cutaneous Abscesses Successfully Treated With Filgotinib in Ulcerative Colitis

open access: yesJEADV Clinical Practice, EarlyView.
ABSTRACT We report on a 31‐year‐old male patient diagnosed with active moderate‐to‐severe ulcerative colitis and a history of splenectomy. He was hospitalized due to confluent pustular oral lesions and multiple skin abscesses. After ruling out an infection, we diagnosed pyostomatitis vegetans associated with aseptic abscess syndrome.
C. Dandoy   +6 more
wiley   +1 more source

Is Lactobacillus GG Helpful in Children With Crohn’s Disease? Results of a Preliminary, Open-Label Study

open access: bronze, 2000
Puneet Gupta   +3 more
openalex   +1 more source

Interleukin‐12/23 and Interleukin‐23 Inhibitors for the Treatment of Cutaneous Crohn's Disease: A Case Series From a Multi‐Institutional Registry

open access: yesJEADV Clinical Practice, EarlyView.
ABSTRACT Background Cutaneous Crohn's disease (CCD) is a granulomatous condition of the skin discontiguous from the gastrointestinal tract. Cutaneous disease rarely correlates with intestinal disease and often requires separate treatment. While the use of interleukin‐12/23 (IL‐12/IL‐23) and interleukin‐23 (IL‐23) inhibitors is FDA‐approved for ...
G. E. McKay   +14 more
wiley   +1 more source

Randomized controlled trial of clarithromycin and ethambutol in the treatment of Crohn’s disease [PDF]

open access: bronze, 2001
Richard Goodgame   +6 more
openalex   +1 more source

Exploring the Cutaneous Associations of Crohn's Disease: A Retrospective Study of 108 Patients

open access: yesJEADV Clinical Practice, EarlyView.
ABSTRACT Background The integumentary system provides a window into the overall health of individuals and may display cutaneous manifestations of systemic disease. Crohn's Disease (CD) is a relapsing inflammatory bowel disease that exhibits a significant symptomatic burden on a global scale.
Max E. Oscherwitz   +4 more
wiley   +1 more source

Stricture Formation in Crohn’s Disease

open access: green, 2000
Mark Regan   +3 more
openalex   +2 more sources

Infliximab induces potent anti‐inflammatory and local immunomodulatory activity but no systemic immune suppression in patients with Crohn’s disease [PDF]

open access: bronze, 2001
Freddy Cornillie   +10 more
openalex   +1 more source

Home - About - Disclaimer - Privacy